Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome
about
Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analysesBrain region mapping using global metabolomics.Meta-analysis of global metabolomic data identifies metabolites associated with life-span extension.Trends in analytical atomic and molecular mass spectrometry in biology and the life sciences.Nanostructured solid substrates for efficient laser desorption/ionization mass spectrometry (LDI-MS) of low molecular weight compounds.Lipidomics at the interface of structure and function in systems biologyProfiling and Imaging Ion Mobility-Mass Spectrometry Analysis of Cholesterol and 7-Dehydrocholesterol in Cells Via Sputtered Silver MALDILaser desorption ionization of small molecules assisted by tungsten oxide and rhenium oxide particles.Molecular Imaging of Biological Samples on Nanophotonic Laser Desorption Ionization Platforms.Development of an Imaging Mass Spectrometry Technique for Visualizing Localized Cellular Signaling Mediators in Tissues.Direct Analysis of Samples of Various Origin and Composition Using Specific Types of Mass Spectrometry.Metabolite mapping by consecutive nanostructure and silver-assisted mass spectrometry imaging on tissue sections.Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha.Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging.Innovation: Metabolomics: the apogee of the omics trilogy.Autism spectrum disorder: an omics perspective.The evolution of lipidomics through space and time.Smith-Lemli-Opitz syndrome.
P2860
Q28732813-02F59D46-02CA-4801-8356-1BA28BB4A3BDQ30873368-D2680236-3D7D-4EFE-805F-384CB6FAC261Q30881402-04671DCA-9AEE-4C8A-8CF2-C5229A24A668Q33781313-068E6766-4A48-4981-AE45-C639F8E6F33FQ35019569-A278E02C-BBF3-4231-993A-D0318885A6BAQ35095381-1FA501F1-2686-439F-8FA0-F6C8083A4DC6Q35590293-40A2DF31-8713-4255-AA08-4FE3CDC1293EQ35767077-A526E0A1-09AC-4E30-BD59-BEC70FCF3556Q35940442-F1613B7A-A8F6-49D7-8568-598088D5192AQ35969085-8EA01F31-5AF8-413E-B31F-0A6E1E8CFBC3Q36311787-B1BFF366-F0A9-4652-B3E4-1824B318D054Q36332587-41A08A92-3396-4B08-A5EC-34ED8904A208Q36949274-20125E9E-7196-497E-BD68-683A0C19665BQ37326605-094A5DE5-4291-4E7B-8445-E0861B79929EQ37995821-78B524FA-DB51-4D9E-9C6A-1E53649A8B79Q38259780-4BF08EBA-39D4-4E1C-B09A-7AA07092C6B5Q39273619-F34F0297-9251-42AB-A08C-C360FCF77D5EQ41828275-EC4E22AC-5786-409B-9C90-93409AAF6A5E
P2860
Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@ast
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@en
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@nl
type
label
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@ast
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@en
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@nl
prefLabel
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@ast
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@en
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@nl
P2093
P2860
P50
P1433
P1476
Nanostructure-initiator mass s ...... in Smith-Lemli-Opitz syndrome
@en
P2093
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2010.07.038
P407
P577
2010-07-27T00:00:00Z